PANCREAZE (Janssen Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the PANCREAZE drug offered from Janssen Pharmaceuticals, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Janssen Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | PANCRELIPASE |
SUBSTANCE NAME: | PANCRELIPASE LIPASE; PANCRELIPASE AMYLASE; PANCRELIPASE PROTEASE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, DELAYED RELEASE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2010-04-12 |
END MARKETING DATE: | 0000-00-00 |
PANCREAZE HUMAN PRESCRIPTION DRUG Details:
Item Description | PANCREAZE from Janssen Pharmaceuticals, Inc. |
LABELER NAME: | Janssen Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 4200; 24600; 14200([USP’U]/1; [USP’U]/1; [USP’U]/1) |
START MARKETING DATE: | 2010-04-12 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 50458-341_c9e43d34-a442-4db8-82b8-636f9ca562a2 |
PRODUCT NDC: | 50458-341 |
APPLICATION NUMBER: | NDA022523 |
Other PANCRELIPASE LIPASE; PANCRELIPASE AMYLASE; PANCRELIPASE PROTEASE Pharmaceutical Manufacturers / Labelers: